Meiji Holdings Co., Ltd. · TSE:2269

Meiji — Investor Presentation (June 2017)

28 slides from Meiji's investor presentation, Jun 19, 2017

Slide 1: Wiah br +I ARAS AL
2017.6.19 Wiah br +I ARAS AL
Slide 4: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Copyrightⓒ2017QuintilesIMS. Calculated based on
+8.8% 108,378 -3.8% 104,307 +4.8% -0.6% 100,165 99,587 +0.3% +5.5% 95,349 95,601 2011 2012 2013 2014 2015 2016 Copyrightⓒ2017QuintilesIMS. Calculated based on JPM 2017 Mar MAT 4 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Reprinted with permission
Slide 5: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Copyrightⓒ2017QuintilesIMS. Calculated based on
-2.6 +3% 4% 103,790 1,183 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 29 Copyrightⓒ2017QuintilesIMS. Calculated based on JPM 2017 Mar MAT 5 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Reprinted with permission
Slide 9: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.
1,756 1,645 1,616 101 110 401 419 387 299 57 190 215 430 425 483 15 16 17 ( 15 16 17 ( ) 9 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.
Slide 11: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Copyrightⓒ2017QuintilesIMS. Calculated based on
( ) ( ) 25 25 20% 20% 20 20 17% 14.1% 14.3% 15 15 10.4% 10 10 5 5 0 0 14 15 16 18 20 14 15 16 18 20 Copyrightⓒ2017QuintilesIMS. Calculated based on JPM 2017 Mar MAT 11 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Reprinted with permission
Slide 12: A H I
1 A 32.8% ↑ 1 H 29.3% ↑ 2 15.1% ↑ 2 I 19.2% ↓ 3 B 11.3% ↑ 3 J 10.3% ↓ 4 C 8.4% ↓ 4 K 8.9% ↓ 5 D 5.7% ↑ 5 L 5.8% ↑ 6 E 5.4% ↓ 6 M 5.2% ↑ 7 F 4.2% ↑ 7 N 5.1% ↓ 8 G 4.0% ↑ 8 O 1.6% ↓ 9 1.3% ↓ 9 1.4% 10 1.1% ↑ 10 1.3% Copyrightⓒ2017QuintilesIMS. Calculated based on JPM 2017 Mar MAT 12 2017.06.19 Copyrig
Slide 13: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source : Kato M,
  13 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source : Kato M, et al. J Psychiatr Res 2017; 89: 97-104
Slide 16: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.
15-16 419 434  ← 47  239 387 401  14 15 16 17   110 120 16 16 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.
Slide 21: 21
21
Slide 24: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source:
100 117.8 95 99 116.8 90 94 109.3 85 89 102.6 80 84 92.2 75 79 77.7 70 74 61.9 65 69 45.4 60 64 35.8 55 59 27.5 50 54 21.6 45 49 16.9 40 44 13.7 35 39 12.1 30 34 10.9 25 29 9.2 20 24 7.3 15 19 7 10 14 8.8 5 9 12.1 0 4 22.2 0 20 40 60 80 100 120 140 0 20 40 60 80 100 120 140 24 2017.06.19 Copyright ©
Slide 25: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source: Healthcare Infection Society
25 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source: Healthcare Infection Society UK
Slide 26: Kato M, et al. J Psychiatr Res 2017; 89: 97-104 Copyright © 2017 Meiji
Kato M, et al. J Psychiatr Res 2017; 89: 97-104 26 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.
Slide 27: BnUSD Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.
BnUSD 20 15 10 5 0 (Million USD) 27 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source: BMI Research, visiongain2016
Slide 28: Overseas pharmaceutical subsidiaries
1. P.T. Meiji Indonesian Pharmaceutical Industries P.T. Meiji Indonesian 2 3   1  3. Medreich 2. Thai Meiji Pharmaceutical      Thai Meiji 28 2017.06.19 Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Meiji Holdings — Investor Presentation (June 2017) on 6ix

Meiji — Investor Presentation (June 2017)

Slide 1: Wiah br +I ARAS AL

Slide 2: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 3: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 4: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Copyrightⓒ2017QuintilesIMS. Calculated based on

Slide 5: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Copyrightⓒ2017QuintilesIMS. Calculated based on

Slide 6: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source:

Slide 7: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 8: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 9: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 10: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 11: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Copyrightⓒ2017QuintilesIMS. Calculated based on

Slide 12: A H I

Slide 13: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source : Kato M,

Slide 14: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 15: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 16: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 17: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 18: Afidopyropene, Flometoquin, Fenpicoxamid

Slide 19: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 20: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 21: 21

Slide 22: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 23: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 24: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source:

Slide 25: Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved. Source: Healthcare Infection Society

Slide 26: Kato M, et al. J Psychiatr Res 2017; 89: 97-104 Copyright © 2017 Meiji

Slide 27: BnUSD Copyright © 2017 Meiji Holdings Co., Ltd. All rights reserved.

Slide 28: Overseas pharmaceutical subsidiaries